Antibiotic administration via indwelling peritoneal catheter to treat infected malignant ascites
Open Access
- 17 October 2022
- journal article
- research article
- Published by Wiley in Respirology Case Reports
- Vol. 10 (11) , e01055
Abstract
Indwelling pleural catheter is an established management for malignant pleural effusions. Extending its use to patients with malignant ascites by insertion of a catheter intraperitoneally enables regular outpatient drainage and improves quality‐of‐life. However, indwelling pleural/peritoneal catheter (IPC/IPeC) is associated with catheter‐related infections, traditionally managed with systemic antibiotics and occasionally requires catheter removal. Direct administration of antibiotics intra‐abdominally via peritoneal dialysis (PD) catheters is a well‐established, efficacious practice in PD‐related peritonitis and minimizes systemic adverse effects. We applied the same principles to a patient with peritoneal mesothelioma who developed peritonitis 3 weeks after insertion of IPeC. Intraperitoneal vancomycin was administered via, and compatible with, the IPeC. The patient tolerated the treatment without adverse effects and made a full recovery without requiring catheter removal.Keywords
This publication has 3 references indexed in Scilit:
- Use of indwelling pleural/peritoneal catheter in the management of malignant ascites: a retrospective study of 48 patientsInternal Medicine Journal, 2019
- Chronic peritoneal indwelling catheters for the management of malignant and nonmalignant ascitesBaylor University Medical Center Proceedings, 2018
- Clinical Outcomes of Indwelling Pleural Catheter-Related Pleural InfectionsChest, 2013